FOXL2 and SOX9 distinguish the lineage of the sex cord-stromal cells in gonadoblastomas

Pediatric and Developmental Pathology

Volumn 14, Issue 5, 2011, Pages 391-395

  Buell Gutbrod, Rebecca ^a   Ivanovic, Marina ^a   Montag, Anthony ^a   Lengyel, Ernst ^a   Fadare, Oluwole ^b   Gwin, Katja ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Dysgerminoma; FOXL2; Gonadoblastoma; Intratubular germ cell neoplasia; Mixed germ cell sex cord stromal cell tumors; SOX9

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; PARAFFIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DYSGERMINOMA; FEMALE; GERM CELL; GERM CELL TUMOR; GONADOBLASTOMA; GRANULOSA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRATUBULAR GERM CELL NEOPLASIA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SERTOLI CELL; SEX CORD STROMA CELL; SEX DETERMINATION; STROMA CELL;

ADOLESCENT; CELL LINEAGE; CELL NUCLEUS; CHILD, PRESCHOOL; DYSGERMINOMA; FORKHEAD TRANSCRIPTION FACTORS; GONADOBLASTOMA; HUMANS; MALE; SEX CORD-GONADAL STROMAL TUMORS; SOX9 TRANSCRIPTION FACTOR; STROMAL CELLS; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84855403102     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/10-12-0943-OA.1     Document Type: Article

References (32)

1. Koopman P. The delicate balance between male and female sex determining pathways: potential for disruption of early steps in sexual development. Int J Androl 2010;33:252-258.
2. Hersmus R, de Leeuw BH, Wolffenbuttel KP, et al. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development. Mol Cell Endocrinol 2008;291:1-10.
3. Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LHJ. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006;27:468-484. (Pubitemid 44213228)
4. Barbaux S, Niaudet P, Gubler MC, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997;17:467-470. (Pubitemid 27518399)
5. Hertel JD, Huettner PC, Dehner LP, Pfeifer JD. The chromosome Y-linked testis-specific protein locus TSPY1 is characteristically present in gonadoblastoma. Hum Pathol 2010;41:1544-1549.
6. Ebel JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press, 2004;220-249.
7. Sekido R. SRY: a transcriptional activator of mammalian testis determination. Int J Biochem Cell Biol 2009;42:417-420.
8. Sekido R, Bar I, Narváez V, Penny G, Lovell-Badge R. SOX9 is upregulated by the transient expression of SRY specifically in Sertoli cell precursors. Dev Biol 2004;274:271-279. (Pubitemid 39302491)
9. Sekido R, Lovell-Badge R. Sex determination and SRY: down to a wink and a nudge? Trends Genet 2009;25:19-29.
10. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/ epicanthus inversus syndrome. Nat Genet 2001;27:159-166. (Pubitemid 32157442)
11. Carlsson P, Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 2002;250:1-23.
12. Uhlenhaut NH, Treier M. Foxl2 function in ovarian development. Mol Genet 2006;88:225-234. (Pubitemid 43963439)
13. Ivanovic M, Lengyel E, Montag A, Gwin K. FOXL2 - a novel marker for granulosa cell tumors. Mod Pathol 2010;23:248A.
14. Shah SP, Köbel M, Senz J, et al. Mutation of FOXL2 in granulosacell tumors of the ovary. N Engl J Med 2009;360:2719-2729.
15. Uhlenhaut NH, Jakob S, Anlag K, et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 2009;139:1130-1142.
16. Sinclair A, Smith C. Females battle to suppress their inner male. Cell 2009;139:1051-1053.
17. Hersmus R, Kalfa N, De Leeuw BH, et al. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD). J Pathol 2008;215:31-38. (Pubitemid 351619873)
18. Wilhelm D, Washburn LL, Truong V, Fellous M, Eicher EM, Koopman P. Antagonism of the testis- and ovary-determining pathways during ovotestis development in mice. Mech Dev 2009;126:324-336.
19. Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child 2006 Jun;2(3): 554-563. (Pubitemid 44023350)
20. Emerson RE, Ulbright TM. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. Pathology 2010;42:344-355.
21. Scully RE. Gonadoblastoma; a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer 1953;6:455-463.
22. Talerman A, Roth LM. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives. Int J Gynecol Pathol 2007;26:313-321. (Pubitemid 46986069)
23. Robboy SJ, Mutter GL, Prat J, Bentley R, Russell P, Anderson MC. Robboy's Pathology of the Female Reproductive Tract, 2nd ed. New York: Churchill Livingstone Elsevier Limited, 2009;945-978.
24. Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Tract. Lyon: IARC Press, 2003;163-179.
25. Pena-Alonso R, Nieto K, Alvarez R, et al. Distribution of Y-chromosome- bearing cells in gonadoblastoma and dysgenetic testis in 45,X/46,XY infants. Mod Pathol 2005;18:439-445. (Pubitemid 40395364)
26. Schumacher V, Gueler B, Looijenga LH, et al. Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome. Mol Reprod Dev 2008;75:1484-1494. (Pubitemid 352032537)
27. Looijenga LH, Hersmus R, Oosterhuis JW, Cools M, Drop SL, Wolffenbuttel KP. Tumor risk in disorders of sex development (DSD). Best Pract Res Clin Endocrinol Metab 2007;21:480-495. (Pubitemid 47393445)
28. Looijenga LH. Human testicular (non) seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol 2009;218:146-162.
29. Cools M, Boter M, Van Gurp R, et al. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads. Clin Endocrinol 2007;67:184-192. (Pubitemid 47076290)
30. Slowikowska-Hilczer J, Romer TE, Kula K. Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype. J Androl 2003;24:270-278.
31. Capito C, Leclair MD, Arnaud A, et al. 46,XY pure gonadal dysgenesis: clinical presentations and management of the tumor risk. J Pediatr Urol 2011;7:72-75.
32. Cools M, Stoop H, Kersemaekers AF, et al. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab 2006;91:2404-2413. (Pubitemid 43855034)